HRT Financial’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $254K | Buy |
280,077
+71,159
| +34% | +$64.5K | ﹤0.01% | 1658 |
|
|
2025
Q1 | $94K | Buy |
+208,918
| New | +$94K | ﹤0.01% | 1925 |
|
|
2024
Q1 | – | Sell |
-35,923
| Closed | -$39K | – | 2584 |
|
|
2023
Q4 | $39K | Buy |
+35,923
| New | +$39K | ﹤0.01% | 1811 |
|
|
2023
Q3 | – | Sell |
-744,628
| Closed | -$1.05M | – | 2542 |
|
|
2023
Q2 | $1.05M | Buy |
744,628
+495,248
| +199% | +$698K | 0.01% | 860 |
|
|
2023
Q1 | $374K | Buy |
249,380
+229,171
| +1,134% | +$344K | ﹤0.01% | 1458 |
|
|
2022
Q4 | $23K | Buy |
+20,209
| New | +$23K | ﹤0.01% | 1974 |
|
|
2022
Q1 | – | Sell |
-135,074
| Closed | -$330K | – | 3199 |
|
|
2021
Q4 | $330K | Buy |
+135,074
| New | +$330K | ﹤0.01% | 1970 |
|
|
2021
Q2 | – | Sell |
-289,018
| Closed | -$679K | – | 3063 |
|
|
2021
Q1 | $679K | Buy |
+289,018
| New | +$679K | 0.01% | 1387 |
|